<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Volgograd State Medical University</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Volgograd State Medical University</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Волгоградского государственного медицинского университета</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-9480</issn><issn publication-format="electronic">1994-9499</issn><publisher><publisher-name xml:lang="en">Volgograd State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">119096</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">NATIONAL CLINICAL RECOMMENDATIONS FOR OBESITY: CONCEPT AND PROSPECTS</article-title><trans-title-group xml:lang="ru"><trans-title>НАЦИОНАЛЬНЫЕ КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ ПО ОЖИРЕНИЮ: КОНЦЕПЦИЯ И ПЕРСПЕКТИВЫ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nedogoda</surname><given-names>S. V</given-names></name><name xml:lang="ru"><surname>Недогода</surname><given-names>Сергей Владимирович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, зав. кафедрой терапии и эндокринологии ФУВ</p></bio><email>nedogodasv@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barykina</surname><given-names>I. N</given-names></name><name xml:lang="ru"><surname>Барыкина</surname><given-names>И. Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра терапии и эндокринологии ФУВ</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Salasyuk</surname><given-names>A. S</given-names></name><name xml:lang="ru"><surname>Саласюк</surname><given-names>А. С</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра терапии и эндокринологии ФУВ</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volgograd State Medical University</institution></aff><aff><institution xml:lang="ru">Волгоградский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2017</year></pub-date><volume>14</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2017)</issue-title><issue-title xml:lang="ru">№1 (2017)</issue-title><fpage>134</fpage><lpage>140</lpage><history><date date-type="received" iso-8601-date="2022-12-18"><day>18</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Nedogoda S.V., Barykina I.N., Salasyuk A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Недогода С.В., Барыкина И.Н., Саласюк А.С.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Nedogoda S.V., Barykina I.N., Salasyuk A.S.</copyright-holder><copyright-holder xml:lang="ru">Недогода С.В., Барыкина И.Н., Саласюк А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/1994-9480/article/view/119096">https://journals.eco-vector.com/1994-9480/article/view/119096</self-uri><abstract xml:lang="en"><p>The article deals with metabolic and hemodynamic disorders, as well as the pathologics of organs and systems associated with obesity. The prerequisites for the creation of new national clinical guidelines «Diagnosis, treatment, prevention of obesity and related diseases» are given.</p></abstract><trans-abstract xml:lang="ru"><p>В статье идет речь о ряде метаболических и гемодинамических нарушений, а также патологий органов и систем, ассоциированых с ожирением. Приводятся предпосылки для создания новых национальных клинических рекомендаций «Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний».</p></trans-abstract><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>metabolic syndrome</kwd><kwd>cardiometabolic risk</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>метаболический синдром</kwd><kwd>кардиометаболический риск</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Бондаренко И.З. и др. Лечение морбидного ожирения у взрослых. Национальные клинические рекомендации // Ожирение и метаболизм. - 2011. - № 3.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Клинические рекомендации по бариатрической и метаболической хирургии Российское общество хирургов, Общество бариатрических хирургов, 2014.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Мировая статистика здравоохранения, 2013 г. - Режим доступа: http://apps.who.int/iris/bitstream/10665/81965/7/9789244564585_rus.pdf?ua=1</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Мычка В.Б., Жернакова Ю.В., Чазова И.Е. Рекомендации экспертов всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома (второй пересмотр) // Доктор. ру - 2010. - № 3. - С. 15-18.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Alberti K., et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. - 2009. - Vol. 120, № 16. - Р. 1640-1645.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Alberti K., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation // Diabetic medicine. - 2006. - Vol. 23, № 5. - Р. 469-480.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>AlDaghri N.M., et al. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances // European journal of clinical investigation. - 2013. - Vol. 43, № 2. - Р. 183-189.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Amato M.C., et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population // Lipids Health Dis. - 2011. - Vol. 10, № 183. - Р. 1-8.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Apovian C.M., et al. Pharmacological management of obesity: an endocrine society clinical practice guideline // The Journal of Clinical Endocrinology &amp; Metabolism. - 2015.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Benetos A., Thomas F., Pannier B., Bean K., Jego B., Guize L. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome // Am J Cardiol. - 2008. - Vol. 102. - Р. 188-191.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Fried M. et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery // Obes Surg. - 2014. - Vol. 24, №. 1. - Р. 42-55.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gallagher E.J., LeRoith D., Karnieli E. The metabolic syndrome-from insulin resistance to obesity and diabetes // Medical Clinics of North America. - 2011. - Vol. 95, № 5. - Р. 855-873.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Garvey W., et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease // Endocrine Practice. - 2014.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Grundy S.M., et al. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute / American Heart Association Conference on scientific issues related to definition // Circulation. - 2004. - Vol. 109, № 3. - Р. 433-438.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Guo F., Garvey W.T. Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes // The Journal of Clinical Endocrinology &amp; Metabolism. - 2015. - Vol. 100, № 10. - Р. 3871-3877.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Guo F., Moellering D.R., Garvey W.T. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity //Obesity. - 2014. - Vol. 22, № 1. - Р. 110-118.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Jakicic J.M., et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. - 2013.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jensen M.D., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society // Journal of the American College of Cardiology. - 2014. - Vol. 63, № 25. - Р. 2985-3023.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Junien C., Nathanielsz P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes // Obesity Reviews. - 2007. - Vol. 8, №. 6. - Р. 487-502.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kassi E., et al. Metabolic syndrome: definitions and controversies // BMC medicine. - 2011. - Vol. 9, № 1. - Р. 48.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lorenzo C., et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes // Diabetes care. - 2007. - Vol. 30, № 1. - Р. 8-13.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Mohammadreza B., et al. Prognostic significance of the complex «Visceral Adiposity Index» vs. simple anthropometric measures: Tehran lipid and glucose study // Cardiovasc Diabetol. - 2012. - Vol. 11. - Р. 20.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Nilsson P.M., Engstrom G., Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in nondiabetic subjects: a population-based study comparing three different definitions // Diabet Med. - 2007. - Vol. 24. - Р. 464-472.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>O'Neill S., O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies // Оbesity reviews. - 2015. - Vol. 16, № 1. - Р. 1-12.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Physical Activity Guidelines Advisory Committee et al. Physical activity guidelines for Americans. Washington, DC: US Department of Health and Human Services. - 2008. - Р. 15-34.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Prasad H., et al. Metabolic syndrome: definition and therapeutic implications //Postgraduate medicine. - 2012. - Vol. 124, № 1. - Р. 21-30.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Rahavi E., et al. Updating the Dietary Guidelines for Americans: Status and Looking Ahead // Journal of the Academy of Nutrition and Dietetics. - 2015. - Vol. 115, № 2. - Р. 180-182.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Seger J.C., et al. American Society of Bariatric Physicians Obesity Algorithm: Adult Adiposity Evaluation and Treatment. - 2013.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Seger J.C., et al. Obesity algorithm, presented by the American Society of Bariatric Physicians. - 2014.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Stegenga H., et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance // BMJ. - 2014. - Vol. 349. - Р. g6608.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Stenholm S., et al. Sarcopenic obesity-definition, etiology and consequences // Current opinion in clinical nutrition and metabolic care. - 2008. - Vol. 11, № 6. - Р. 693.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Yang F., et al. Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness. - 2014.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Yumuk V., et al. An EASO position statement on multidisciplinary obesity management in adults // Obesity facts. - 2014. - Vol. 7, № 2. - Р. 96-101.</mixed-citation></ref></ref-list></back></article>
